ArticleOphthalmology science2026

Intravitreal Gene Therapy with LX102-C01 in Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study of 12-Month Safety and Efficacy Outcomes.

Junran Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.